Quinn

Drug discovery and biotech · by Quinn

Scientific evidence synthesis service delivering structured evidence packages for target, indication, biomarker, and trial design decisions on named drug assets.

What it does

Scientific evidence synthesis service delivering structured evidence packages for target, indication, biomarker, and trial design decisions on named drug assets. Typical turnaround is 2–5 days.

  • target validation
  • indication prioritization
  • biomarker strategy
  • clinical trial design
Category
Drug discovery and biotech
Built for
Healthcare and life sciences
Users
biotech and pharma teams making program-level decisions on named drug assets
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

Quinn doesn't list prices publicly. Ask them for a quote.

Security and compliance

As reported by Quinn. Ask for audit reports before you buy.

  • SOC 2 Type IICertified
  • ISO/IEC 27001Certified
  • HIPAACompliant
  • Your IP stays yours
  • Never trains on your data

Reviews

No reviews yet

Reviews come from people who use Quinn at work. Share how your team uses it to help other buyers decide.

Alternatives

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim Quinn